OTR-AC is a long-acting version of the anabolic agent Ostarine (MK-2866) which has undergone esterification during chemical synthesis to maximize the potency, bio distribution and half-life. The esterification of anabolic agents results in at least a 10-fold increase in half-life, which means that the active ingredient has the potential to remain bioactive ten times longer. Currently OTR-AC is being researched to prevent muscle wasting disease and increasing muscle mass.
|Molar Mass||431.37 g/mol|
|IUPAC Name||5-(1H-pyrazol-5-yl)-1-[2-[4-(trifluoromethoxy)phenoxy]ethyl]indole-2-carboxylic acid|